Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (DHR)
NYSE:DHR
Danaher (DHR) Stock Price & Analysis
2,545 Followers
DHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$181.51 - $268.82
Previous Close$240
Volume1.39M
Average Volume (3M)3.02M
Market Cap
$177.22B
Enterprise Value$195.93B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$18.16B
Price to Earnings (P/E)40.7
Beta1.10
Next Earnings
Jul 23, 2024EPS Estimate
$1.58Last Dividend Ex-Date
Jun 28, 2024Dividend Yield0.44%
Share Statistics
EPS (TTM)5.90
Shares Outstanding740,686,541
10 Day Avg. Volume4,089,542
30 Day Avg. Volume3,017,000
Standard Deviation0.07
R-Squared0.40
Alpha0.00550
Financial Highlights & Ratios
Price to Book (P/B)-25.90
Price to Sales (P/S)7.91
Price to Cash Flow (P/CF)27.20
P/FCF Ratio31.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.70
Enterprise Value/Gross Profit13.96
Enterprise Value/Ebitda27.88
Forecast
1Y Price Target
$275.25Price Target Upside15.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Danaher News
PremiumCompany Announcements
Danaher Executive VP Joakim Weidemanis Plans Resignation
Bulls Say, Bears Say
Bulls Say
Bioprocessing OrdersBioprocessing orders showed a positive surprise by increasing mid-single digits sequentially, indicating growing demand.
Market LeadershipAnalysts consider DHR a sector leader with a market-leading franchise in bioprocessing and a strong position as a consolidator in Life Science Tools and Diagnostics.
Revenue And EarningsDHR announced $5.8B revenue in 1Q24, driven by a strong performance in the Biotech segment.
Bears Say
Foreign Exchange ImpactFX turned negative for Danaher and is now a -1% headwind to FY revenues.
Sales PerformanceChina continues to be soft, with sales in the region declining high teens in 1Q, including -40% in the Biotechnology segment.
ValuationThe medium-term outlook remains constructive though near-term valuation is starting to feel a bit stretched.
---
Ownership Overview
9.18% Insiders
28.19% Mutual Funds
16.79% Other Institutional Investors
45.84% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DHR FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest stock price was $181.51 and its highest was $268.82 in the past 12 months.
What is Danaher Corp.’s market cap?
Currently, no data Available
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Jul 23, 2024 which is in 18 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Apr 23, 2024. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.717 by $0.203.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.44%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is $1.58.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 740,686,500 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $1.92 in its last earnings report, beating expectations of $1.717. Following the earnings report the stock price went up 7.213%.
Which hedge fund is a major shareholder of Danaher Corp.?
Among the largest hedge funds holding Danaher Corp.’s share is Fisher Asset Management LLC. It holds Danaher Corp.’s shares valued at 1B.
---
Danaher Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$275.25 (15.04% Upside)
$275.25 (15.04% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 2.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $18.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.84%
12-Months-Change
Fundamentals
Return on Equity
8.47%
Trailing 12-Months
Asset Growth
-1.93%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
DHR Company Deck
---
DHR Earnings Call
Q1 2024
0:00 / 0:00
---
DHR Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
DHR Stock 12 Month Forecast
Average Price Target
$275.25
▲(15.04% Upside)
Technical Analysis
Best Analysts Covering DHR
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+5.36%
reiterated a buy rating 2 months ago
Copying Justin Bowers's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +5.36% per trade.
---